Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors.
Yoichi NaitoSaori MishimaKiwamu AkagiNaomi HayashiAkira HirasawaTomoro HishikiAtaru IgarashiMasafumi IkedaShigenori KadowakiHiroaki KajiyamaMotohiro KatoHirotsugu KenmotsuYasuhiro KoderaKeigo KomineTakafumi KoyamaOsamu MaedaMitsuru MiyachiHiroshi NishiharaHiroyuki NishiyamaShouichi OhgaWataru OkamotoEiji OkiShigeru OnoMasashi SanadaIkuo SekineTadao TakanoKayoko TaoKeita TerashimaKatsuya TsuchiharaYasushi YatabeTakayuki YoshinoEishi BabaPublished in: International journal of clinical oncology (2023)
The committee proposed 14 recommendations for performing NTRK testing properly to select patients who are likely to benefit from TRK inhibitors.